FirsthandHealth
medRxiv PreprintsInternational17 November 2026

Integrated Genomic and Transcriptomic Profiling Reveals Distinct Biological Programs and Therapeutic Opportunities in Cancer of Unknown Primary

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background: Cancer of unknown primary (CUP) is a metastatic, heterogeneous malignancy accounting for 2-5% of cancer diagnoses globally. Failure to identify the primary site precludes tumor-type-specific therapy and, together with an aggressive clinical course, contributes to poor survival. The biological mechanisms driving these behaviors remain poorly understood. A deeper understanding of CUP biology is therefore essential to improve diagnostic precision and therapeutic strategies. To address this knowledge gap, we comprehensively characterized the multi-omics landscape of CUP and identified
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.